Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 09, 2026
Torrid Holdings (CURV): Is the $3 Level on the Horizon?

Torrid Holdings (CURV): Is the $3 Level on the Horizon?

Key Takeaways

  • Torrid Holdings Inc. (CURV) trades near $2.50, with a 52-week high of $2.86, making the $3 level a meaningful psychological and technical milestone roughly 20% above recent prices.
  • The strongest bullish case rests on a turnaround that is finally showing traction, including positive comparable-store sales in July and August and improving profitability guidance.
  • The biggest obstacles are a multi-year revenue decline, persistent net losses, heavy debt, and a Wall Street consensus that still averages well below the current share price.
  • Resistance sits at the 52-week high of $2.86, while support zones include the 50-day moving average near $2.24 and the 200-day average near $1.62.
  • Reaching $3 would require Torrid to decisively break above its prior high and sustain the sales and margin momentum that analysts have so far treated with caution.

Why the $3 Mark Stands Out

Torrid Holdings Inc., a plus-size women's apparel retailer operating the Torrid, Torrid Curve, and Lovesick brands, has staged a remarkable recovery from its 52-week low of $0.94. The stock now changes hands near $2.50, a gain of more than 150% year to date. That rebound has put the $3 mark squarely in focus as the next round-number milestone just above the stock's 52-week high of $2.86.

Unlike a distant objective, $3 is a nearby, psychologically significant target. It represents the first clean whole-dollar level that would require CURV to print a fresh multi-year high, confirming that the turnaround is more than a dead-cat bounce. At the same time, it is far enough away, roughly 20%, to avoid being reached in a single routine session. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position

Torrid trades with a market capitalization near $249 million and a price-to-sales ratio of about 0.26, reflecting how deeply discounted the shares remain relative to trailing revenue of roughly $949 million. The company has been unprofitable on a trailing basis, posting a net loss of about $9 million and negative earnings per share, although losses have narrowed meaningfully from the prior year. The balance sheet carries roughly $417 million in debt against about $22 million in cash, giving the stock a leveraged profile typical of a specialty retailer in transition.

What Could Drive the Next Leg Higher

The core of the bull case is operational, not speculative. After a period of store closures and product missteps, management has focused on store optimization, sourcing gains, and tariff normalization, alongside new sub-brands designed to broaden the customer base. Early evidence suggests the strategy is working: same-store sales turned positive in July, with strength continuing into August, and full-year 2026 guidance points to meaningful margin expansion in the back half of the fiscal year.

That progress was reflected in analyst action after the company's second-quarter report. BofA raised its price target to $2.70 from $2.25 while keeping a Buy rating, and lifted its fiscal 2026 and 2027 EBITDA estimates. If Torrid can convert improving comparable sales into sustained profitability, a re-rating toward and beyond $3 becomes more plausible, particularly given how low the valuation multiple remains.

What Could Prevent the Move

The bear case is equally concrete. Revenue has contracted for several consecutive years, falling from about $1.3 billion in fiscal 2022 toward $1.0 billion in fiscal 2026, as the company reduced its store footprint. The elevated debt load and negative free cash flow leave limited room for error, while heavy short interest, roughly 16% of the public float, indicates that a substantial segment of the market is betting against a durable recovery.

Wall Street's consensus also remains cautious. The average analyst price target sits near $1.62 to $1.81, below the current price, with the lowest target at $0.75 from Goldman Sachs and the highest at $2.70 from BofA. Even the most bullish published target is still below $3, meaning the stock would need to exceed every current Street forecast to reach the level in question.

Technical Levels That Matter

From a technical analysis perspective, $2.86, the 52-week high, is the immediate resistance level that must be cleared before $3 becomes reachable. That zone also aligns with prior supply, where sellers have previously absorbed buying pressure. On the downside, the 50-day moving average near $2.24 and the 200-day moving average near $1.62 mark important support levels that would need to hold for the broader uptrend to remain intact.

Monitoring with AI Daily Buy/Sell Signals

Traders tracking volatile small-cap names like Torrid can also use tools such as Tickeron's AI Daily Buy/Sell Signals. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I find this helpful for staying on top of fast-moving turnaround situations without having to sift through every chart manually.

Final Assessment

Can Torrid reach $3? The path exists, but it is not assured. The strongest argument in favor is that the operational turnaround is demonstrably gaining traction, with improving comparable sales, rising EBITDA estimates, and a deeply discounted valuation providing a potential catalyst for multiple expansion. Clearing the $2.86 high and holding it would open the door to a test of $3.

Against that, the stock faces a multi-year revenue decline, ongoing losses, substantial leverage, and a consensus analyst price target that still trails the current quote. Reaching $3 would require Torrid to surpass every published Street target, a feat that hinges on proving the recent sales momentum is durable rather than temporary. Investors should monitor comparable-store sales trends, margin expansion, and any stabilization in revenue as the clearest signposts for whether that round-number milestone becomes attainable.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CURV

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CURV saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for CURV moved out of overbought territory on September 01, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 48 similar instances where the indicator exited the overbought zone. In of the 48 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CURV broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CURV entered a downward trend on August 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CURV's RSI Indicator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 28, 2026. You may want to consider a long position or call options on CURV as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CURV just turned positive on September 04, 2026. Looking at past instances where CURV's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

CURV moved above its 50-day moving average on September 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CURV crossed bullishly above the 50-day moving average on September 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CURV advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CURV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (3.089). P/E Ratio (44.000) is within average values for comparable stocks, (23.252). CURV's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.650). CURV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.034). P/S Ratio (0.262) is also within normal values, averaging (0.699).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CURV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

Notable companies

The most notable companies in this group are TJX Companies (NYSE:TJX), lululemon athletica (NASDAQ:LULU), Gap Inc (The) (NYSE:GAP), Abercrombie & Fitch Co (NYSE:ANF), Stitch Fix (NASDAQ:SFIX).

Industry description

Companies in the apparel and/or footwear retail industry sell clothing, accessories and footwear, for different age groups and genders. The industry’s product categories could range from basics, such as underwear, to luxury items. Some retailers source items from wholesalers or an apparel brand to sell in their stores; some others are licensed to make and market their own retail goods under particular brands. Several companies outsource production of clothing to developing/emerging economies where labor costs are relatively inexpensive. Apparel retail is often influenced by fashion trends, and many companies feel the need to adapt to what’s “in vogue” to retain customers and attract new ones. A major disruption in this industry has been the burgeoning trend in digital shopping – to compete with rapidly growing e-commerce, even traditional retail players are upping the ante on their online platforms. Much of the products’ performance in apparel/footwear retail is cyclical, i.e., economic boom times encourage consumer spending, while recessions induce thriftiness among people. Some large-cap U.S. apparel/footwear retail companies include TJX Companies Inc., Ross Stores, Inc., Lululemon Athletica Inc. and Burlington Stores, Inc.

Market Cap

The average market capitalization across the Apparel/Footwear Retail Industry is 8.65B. The market cap for tickers in the group ranges from 256K to 179.95B. IDEXY holds the highest valuation in this group at 179.95B. The lowest valued company is DESTQ at 256K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Retail Industry was -2%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was 5%. DLTH experienced the highest price growth at 22%, while DBGI experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Retail Industry was 39%. For the same stocks of the Industry, the average monthly volume growth was 118% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 56
Price Growth Rating: 59
SMR Rating: 65
Profit Risk Rating: 88
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
CURV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ApparelFootwearRetail

Profile
Details
Industry
N/A
Address
18501 East San Jose Avenue
Phone
+1 626 667-1002
Employees
5685
Web
https://www.torrid.com
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.